```html

Zebra Lines (Chemotherapy‑Induced Nail Changes)

What is Zebra lines (chemotherapy nail changes)?

Zebra lines are a distinctive pattern of transverse white or gray bands that appear on the fingernails or toenails of patients receiving certain chemotherapy agents. Each band corresponds to a single chemotherapy cycle, producing a “striped” or “zebra‑like” appearance when the nail grows outward. The phenomenon is medically referred to as chemotherapy‑induced melanonychia/onycholysis with transverse leukonychia or simply “zebra lines.” While the pattern is often harmless, it signals that the nail matrix – the tissue that produces the nail plate – has been temporarily disrupted by cytotoxic drugs.

Because nails grow slowly (≈3 mm/month for fingernails, 1 mm/month for toenails), the stripes become visible weeks to months after treatment has started. The condition is purely a cosmetic effect in most cases, but it can be accompanied by nail pain, brittleness, or infection if the nail plate detaches.

Common Causes

The term “zebra lines” is most frequently linked to chemotherapy, yet several other drugs or medical conditions can produce similar transverse nail bands. Below are the most common culprits:

• Alkylating agents – cyclophosphamide, ifosfamide, melphalan.
• Anthracyclines – doxorubicin, epirubicin.
• Taxanes – paclitaxel, docetaxel.
• Platinum compounds – cisplatin, carboplatin.
• Antimetabolites – 5‑fluorouracil, capecitabine.
• Biologic agents – bevacizumab, sunitinib (occasionally cause nail changes).
• Targeted therapies – EGFR inhibitors (erlotinib, gefitinib) can cause onycholysis with transverse ridging.
• High‑dose corticosteroids – prolonged systemic use may produce transient white bands.
• Radiation therapy to the hand/foot – can affect nail matrix growth.
• Systemic diseases – severe malnutrition, uncontrolled diabetes, or psoriasis may mimic the appearance, though true “zebra lines” are drug‑related.

Associated Symptoms

While many patients only notice the cosmetic striping, other nail‑related signs can develop, especially if the nail matrix is more heavily damaged.

• Onycholysis – separation of the nail plate from the nail bed, creating a white or yellow gap.
• Subungual hemorrhage – small red or purple spots under the nail caused by tiny blood vessel leakage.
• Increased brittleness or peeling – nails may become thin, ragged, or split easily.
• Pain or tenderness – especially when the nail starts to lift or if a secondary infection occurs.
• Discoloration – aside from white bands, nails may develop yellow, brown, or black pigmentation (melanonychia).
• Secondary fungal or bacterial infection – the disrupted nail plate is a portal for organisms.

When to See a Doctor

Most zebra lines resolve on their own once chemotherapy is completed, but medical evaluation is warranted if any of the following occur:

• Severe pain, throbbing, or swelling around the nail.
• Rapid detachment of the nail plate (onycholysis) affecting walking or hand function.
• Signs of infection – redness, warmth, pus, foul odor, or fever.
• Sudden appearance of dark or pigmented bands, which could signal melanoma.
• Persistent nail changes that do not improve 6–12 months after ending therapy.
• Difficulty performing daily activities because of nail fragility.

Prompt assessment helps prevent complications such as permanent nail matrix scarring or severe infection.

Diagnosis

Evaluating zebra lines involves a combination of history, physical examination, and sometimes ancillary tests.

1. Detailed Medical History

• Identify chemotherapy regimen, dosing schedule, and total number of cycles.
• Ask about other medications (e.g., antibiotics, antifungals) that may affect nails.
• Review comorbidities such as diabetes, peripheral vascular disease, or nail‑picking habits.

2. Physical Examination

• Inspect all nails for band pattern, width, and distance from the nail fold – the distance often correlates with time elapsed since the last chemotherapy dose.
• Assess for onycholysis, subungual debris, or palpable tenderness.
• Check skin surrounding the nails for signs of infection or inflammatory disease.

3. Diagnostic Tests (when indicated)

• Nail clipping for pathology – if a pigmented band is suspicious for melanoma.
• Culture or KOH preparation – to rule out fungal infection when onycholysis is present.
• Baseline blood work – complete blood count and metabolic panel to assess overall chemotherapy tolerance.

Treatment Options

Therapeutic goals are to protect the nail matrix, manage symptoms, and prevent infection. Treatment is often supportive because the underlying cause (chemotherapy) cannot be stopped without compromising cancer therapy.

Medical Interventions

• Topical antibiotics or antifungals – prescribed if secondary infection is confirmed (e.g., clotrimazole cream, mupirocin ointment).
• Systemic antifungals – oral terbinafine or itraconazole for invasive onychomycosis.
• Pain control – acetaminophen or ibuprofen; for severe pain, a short course of a low‑dose oral corticosteroid may be considered by the oncologist.
• Protective dressings – hydrocolloid or silicone patches over fragile nails to reduce trauma.
• Modification of chemotherapy schedule – in rare cases where nail toxicity is severe, oncologists may adjust dosing or switch to a less nail‑toxic agent.

Home Care Strategies

• Keep nails trimmed short – reduces leverage that can cause tearing.
• File gently – use a fine‑grit nail file to smooth edges; avoid metal files that can traumatize the nail bed.
• Moisturize – apply a fragrance‑free emollient (e.g., petroleum jelly or urea‑based cream) twice daily to prevent cracking.
• Avoid harsh chemicals – limit exposure to detergents, acetone, or nail polish removers; wear cotton gloves when cleaning.
• Use breathable footwear – for toe‑nail involvement, choose shoes with adequate ventilation to reduce moisture accumulation.
• Protect from trauma – avoid picking at the nail plate or using nails as tools.

Prevention Tips

While zebra lines are an unavoidable side effect for many chemotherapy regimens, certain measures can lessen their severity.

• Pre‑treatment nail care – have a professional manicure (without filing the nail matrix) before starting chemotherapy.
• Use cold therapy – applying a cold compress (or a specialized cooling device) to the hands/feet during infusion can reduce drug delivery to the nail matrix (evidence from “cryotherapy” studies, JCO 2020).
• Hydration and nutrition – adequate protein, biotin (2.5 mg daily), and zinc support nail growth.
• Choose nail‑friendly products – silicone‑based nail polish or clear protective coats may shield the nail surface.
• Prompt management of nail trauma – treat cuts or splinters immediately to avoid secondary infection.
• Communicate with the oncology team – report early nail changes; sometimes dose timing can be adjusted without impacting efficacy.

Emergency Warning Signs

---

References:

• Mayo Clinic. “Nail changes associated with chemotherapy.” Accessed May 2024.
• American Cancer Society. “Managing side effects of cancer treatment.” 2023.
• JCO (Journal of Clinical Oncology). “Cryotherapy for prevention of chemotherapy‑induced nail toxicity.” 2020.
• National Institutes of Health, National Cancer Institute. “Chemotherapy‑induced nail changes.” 2022.
• Cleveland Clinic. “Onycholysis and nail disorders.” Updated 2024.

```